Literature DB >> 20617216

Rare lung diseases III: pulmonary Langerhans' cell histiocytosis.

Stephen C Juvet1, David Hwang, Gregory P Downey.   

Abstract

Pulmonary Langerhans' cell histiocytosis (PLCH) is an unusual cystic lung disease that is also characterized by extrapulmonary manifestations. The current review discusses the presenting features and relevant diagnostic testing and treatment options for PLCH in the context of a clinical case. While the focus of the present article is adult PLCH and its pulmonary manifestations, it is important for clinicians to distinguish the adult and pediatric forms of the disease, as well as to be alert for possible extrapulmonary complications. A major theme of the current series of articles on rare lung diseases has been the translation of insights gained from fundamental research to the clinic. Accordingly, the understanding of dendritic cell biology in this disease has led to important advances in the care of patients with PLCH.

Entities:  

Mesh:

Year:  2010        PMID: 20617216      PMCID: PMC2900147          DOI: 10.1155/2010/216240

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  87 in total

Review 1.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

Review 2.  Dendritic cells: understanding immunogenicity.

Authors:  Ralph M Steinman
Journal:  Eur J Immunol       Date:  2007-11       Impact factor: 5.532

3.  Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Société de Pathologie Thoracique du Nord.

Authors:  A Delobbe; J Durieu; A Duhamel; B Wallaert
Journal:  Eur Respir J       Date:  1996-10       Impact factor: 16.671

4.  Severe pulmonary hypertension in histiocytosis X.

Authors:  M Fartoukh; M Humbert; F Capron; S Maître; F Parent; C Le Gall; O Sitbon; P Hervé; P Duroux; G Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

5.  Clinico-epidemiological features of pulmonary histiocytosis X.

Authors:  R Watanabe; K Tatsumi; S Hashimoto; A Tamakoshi; T Kuriyama
Journal:  Intern Med       Date:  2001-10       Impact factor: 1.271

6.  Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology.

Authors:  R S Crausman; C A Jennings; R M Tuder; L M Ackerson; C G Irvin; T E King
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

7.  Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders.

Authors:  M Thomeer; M Demedts; K Vandeurzen
Journal:  Acta Clin Belg       Date:  2001 May-Jun       Impact factor: 1.264

8.  A randomized trial of treatment for multisystem Langerhans' cell histiocytosis.

Authors:  H Gadner; N Grois; M Arico; V Broadbent; A Ceci; A Jakobson; D Komp; J Michaelis; S Nicholson; U Pötschger; J Pritchard; S Ladisch
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

9.  Haemoptysis in eosinophilic granuloma.

Authors:  R K Knight
Journal:  Br J Dis Chest       Date:  1979-04

10.  Evidence for the immunosuppressive role of nicotine on human dendritic cell functions.

Authors:  Mahyar Nouri-Shirazi; Elisabeth Guinet
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

View more
  6 in total

Review 1.  [Increased transparency in thin-slice computed tomography of lung parenchyma].

Authors:  J Ley-Zaporozhan
Journal:  Radiologe       Date:  2011-10       Impact factor: 0.635

Review 2.  18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations.

Authors:  Krishan Kant Agarwal; Rachna Seth; Abhishek Behra; Manisha Jana; Rakesh Kumar
Journal:  Jpn J Radiol       Date:  2016-01-13       Impact factor: 2.374

3.  A Case of Langerhans Cell Histiocytosis with Atypical Radiological Presentation.

Authors:  Murat Türk; Haluk Türktaş; Nalan Akyürek
Journal:  Turk Thorac J       Date:  2014-11-05

4.  Pulmonary Langerhans cell histiocytosis: analysis of 14 patients and literature review.

Authors:  Cheng-Wei Li; Man-Hui Li; Jiang-Xiong Li; Ru-Jia Tao; Jin-Fu Xu; Wei-Jun Cao
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 5.  Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.

Authors:  Hind Abdin Salama; Abdul Rahman Jazieh; Ayman Yahya Alhejazi; Ahmed Absi; Saeed Alshieban; Mohsen Alzahrani; Ahmed Alaskar; Giamal Gmati; Moussab Damlaj; Khadega A Abuelgasim; Abdulrahman Alghamdi; Bader Alahmari; Areej Almugairi; Hazza Alzahrani; Ali Bazarbachi; M O H Musa; Gaurav Goyal
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2020-08-18

6.  Histological and immunohistochemical studies on primary intracranial canine histiocytic sarcomas.

Authors:  Atigan Thongtharb; Kazuyuki Uchida; James Kenn Chambers; Yumiko Kagawa; Hiroyuki Nakayama
Journal:  J Vet Med Sci       Date:  2015-12-12       Impact factor: 1.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.